Nutritional Oncology Biotechnology
Built for what
cancer does
to the body
Nutrovene is the first nutritional supplement formulated specifically for the biological reality of cancer and its treatment — addressing not only clinical outcomes but quality of life across the full cancer journey.
Nutritional oncology. Built for what cancer does.
80%
of cancer patients experience significant nutritional compromise during treatment
50–80%
affected by muscle wasting — responsible for 1 in 5 cancer deaths
60–90%
vitamin D insufficient at diagnosis — an independent prognostic indicator
8 layers
of integrated nutritional support — one daily serving
A product by Nutrobio — Nutritional Oncology Biotechnology
Nutrobio develops nutritional oncology interventions grounded in cancer metabolic science. Nutrovene is Nutrobio’s flagship product — an eight-layer formulation addressing the specific biological demands of cancer and its treatment across prehabilitation, active treatment, and survivorship. Every ingredient is chosen for its oncology-specific rationale, in the form that works in the conditions of cancer treatment.
The clinical problem
Why standard Nutrition is inadequate
Cancer is a disease of metabolic reprogramming that affects energy production, muscle integrity, gut function, immune response, bone density, and neurological health — simultaneously, from the moment of diagnosis. The treatments that fight cancer add their own biological demands on top. Standard dietary advice was not designed for this.
The Warburg Effect
Cancer rewires cellular energy
Cancer cells consume glucose wastefully and force the liver into an energy-expensive recovery cycle. The result is a systemic energy deficit that calories alone cannot address.
Cytokine-driven catabolism
Muscle wasting is not diet failure
Inflammatory cytokines drive muscle breakdown even when protein intake appears adequate. This is why standard protein supplements produce limited results without addressing the metabolic environment.
Mitochondrial dysfunction
Fatigue that rest cannot fix
Cancer-related fatigue is driven by impaired mitochondrial energy production, NAD+ depletion from chemotherapy, and carnitine deficiency. It requires cellular energy solutions, not rest.
The full cancer journey
Three stages
One continuous programme
Nutrovene is formulated for use throughout the full cancer journey — not only during active treatment.
STAGE 1
Prehabilitation
Before treatment begins
Stage 2
Active Treatment
Chemo · Radiation · Surgery · Immunotherapy · Hormone therapy
Stage 3
Survivorship
Remission & long-term recovery
Build nutritional reserves before the biological demands of treatment begin. The nutritional foundation at treatment initiation is one of the strongest predictors of quality of life trajectory throughout.
The most underutilised quality of life intervention in oncology — investing before treatment depletes what cannot easily be rebuilt mid-treatment.
Protein · Minerals · Gut preparation · Immune priming
Sustain nutritional status under maximum demand. Reduce the biological burden of treatment enough to allow patients to remain present in their own lives — not only surviving appointments but living between them.
Maintaining the capacity to work, to be with family, to feel like yourself — these are primary goals, not secondary concerns.
All 8 layers simultaneously
Recovery does not end at remission. 30–40% of survivors experience clinically significant fatigue for years. Gut dysbiosis, bone loss, muscle weakness, and cognitive changes persist long after treatment ends.
The quality of the years after cancer matters as much as surviving to have them.
Immune surveillance · Gut health · Bone · Micronutrients
Nutrovene is formulated for all three stages · One daily serving throughout the cancer journey · Mixed with water or a plant-based alternative